These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up. Forauer AR; Dewey BJ; Seigne JD Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958 [TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR Radiology; 2003 Feb; 226(2):417-24. PubMed ID: 12563135 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes. Park JJ; Park BK; Park SY; Kim CK J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421 [TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR AJR Am J Roentgenol; 2005 Jul; 185(1):64-71. PubMed ID: 15972400 [TBL] [Abstract][Full Text] [Related]